Dose expansion in Phase 1 CARDINAL trial of TERN-701 for chronic myeloid leukemia (CML) expected to initiate in 2Q25 with additional safety and ...

A bacterium makes a molecule that kills drug-resistant fungi in an unusual way — by targeting various phospholipid molecules ...

In this edition of “Rising High,” The Fly conducted an exclusive interview with Jared Stanley, Chief Executive Officer, and Joel Stanley, ...

Investigating sodium carboxymethyl cellulose (NaCMC) effects on graphite anodes, this study reveals key factors influencing lithium-ion battery performance.

Operator: Ladies and Gentlemen, thank you for participating in the Fourth Quarter 2024 Earnings Conference Call of Melco Resorts and Entertainment Limited.

There is no dose titration being necessary at all ... at Week 13 all patients received a two- or four-fold step-up dose. This is not exactly a once-monthly dosing schedule, but the point is ...

Trevi Therapeutics plans to discuss the next steps with the FDA and anticipates initiating the next study after receiving the agency’s input. The positive trial results have clearly resonated with ...

We will continue to show our quality and safety process across every step of the customer journey ... on our platform to personalize successful titration plans and steady state dosages strengthens ...

Learn how drug absorption and predictive modeling drive advancements in pharmaceuticals and precision medicine.

Detailed price information for Terns Pharmaceuticals Inc (TERN-Q) from The Globe and Mail including charting and trades.

Detailed price information for Southern Silver Exploration Corp (SSV-X) from The Globe and Mail including charting and trades.

In this study, doxazosin titration occurred on a monthly basis ... tolerated dose of the initial medication, an open-label step 2 agent (atenolol, 25-100 mg/day; reserpine, 0.05-0.2 mg/day ...